Clinical Trial Update: Role of Activated Charcoal in Decreasing Blood Urea, Creatinine and Phosphorous [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring activated charcoal to decrease blood urea, creatinine, and phosphorus in patients with chronic kidney disease stage 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Activated Charcoal (activated charcoal)

Snippet

Sponsor: Assiut University | Conditions: Chronic Kidney Disease stage3 | Phase 2 | Status: UNKNOWN